Back

Changes in cardiac electrical biomarker with hyperaemic stress: an experimental perspective.

28 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Preclinical and clinical laboratory markers in chronic coronary syndromes Chronic Ischaemia ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Felicia Adjei

Royal Papworth Hospital NHS Foundation Trust, Cambridge (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction
Professor B. Kingwell (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
Mr D. Fueller (Brandenburg an der Havel, DE)
Abstract Slides Video
Presentation thumbnail
Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome
Doctor A. Kallmeyer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Formation of denser plasma fibrin clots is associated with coronary artery ectasias and aneurysms - preliminary results from the CARE-ANEURYSM study
Doctor J. Chmiel (Krakow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Preclinical and clinical laboratory markers in chronic coronary syndromes

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Ischaemic heart disease
thumbnail
Congress Presentation
Functional improvement of non-infarct related coronary artery stenosis by extensive LDL-C reduction with a PCSK9 antibody: the FITTER trial, microvascular function analysis
thumbnail
Congress Presentation
Intracoronary ECG ST-segment shift remission time during reactive coronary hyperemia (tau-icECG): a new approach to assess hemodynamic coronary stenosis severity

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources